New drug MPB-1734 enters human trials for advanced solid tumors
Disease control
Recruiting now
This study tests a new drug called MPB-1734 in adults with advanced solid tumors that no longer respond to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. The trial has two parts: first, finding the right dose in a small group, then tes…
Phase: PHASE1, PHASE2 • Sponsor: MegaPro Biomedical Co. Ltd. • Aim: Disease control
Last updated May 17, 2026 05:22 UTC